extrapulmonary TB

extrapulmonary TB

Infectious disease Clinical TB outside the lungs–eg, lymph nodes, pleura, brain, kidneys, or bones
Mentioned in ?
References in periodicals archive ?
31] There are a multitude of factors that may modulate the sensitivity of IGRA including HIV coinfection, immune suppression, young or advanced age, advanced disease, malnutrition, extrapulmonary TB, disseminated TB, concomitant TB treatment, bacteria strain differences, and smoking.
Cutaneous TB is treated as per the recommendations of therapy for extrapulmonary TB.
Tuberculosis (TB) is one of the most common causes of exudative pleural effusion in India and pleural effusion is the second most common site of extrapulmonary TB after lymph node.
9%; 2) children with new cases of TB were more likely than adults to have extrapulmonary TB or a history of contact with TB patients; 3) [approximately equal to] 18.
Extrapulmonary TB is as common as pulmonary TB in these patients, [27] so in addition to a chest radiograph and sputum Xpert MTB/RIF assay, it is important to consider an ultrasound scan of the abdomen, pericardium and lower chest.
Pulmonary TB was diagnosed in 80% of participants (24% of these cases were cavitary), extrapulmonary TB was diagnosed in 29% of participants, and 79% of TB cases were microbiologically confirmed.
5,6) The ocular system is affected in nearly 20% of extrapulmonary TB patients.
Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children.
8 This case emphasizes the need for increased awareness of extrapulmonary TB by physicians in developed countries.
Musculoskeletal tuberculosis is relatively uncommon and accounts for 1 to 2% of all the tuberculosis patients (2,3) and accounts for about 10% of all extrapulmonary TB infections (4).
Diagnosing extrapulmonary TB is difficult, especially when clinical presentation is suggestive but bacteriological proof is lacking.
This updated edition reflects recent advancements in laboratory diagnostics and subsequent WHO guidance, including Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis, Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children, and Xpert MTB/RIF Implementation Manual.